CERILLIANT™ Cariprazine-D8 Solution, 100 μg/mL (0.1% HCl in Acetonitrile (v/v)), Sold by MilliporeSigma™ Supelco™
Certified reference material
Manufacturer: MilliporeSigma Supelco C1791ML
DescriptionCariprazine, sold as Vraylar in the US and Reagila in Europe, is an atypical antipsychotic used in the treatment of schizophrenia and bipolar mania. This stable-labeled internal standard is suitable for quantitation of Cariprazine levels in urine, serum, or plasma by LC/MS or GC/MS for clinical toxicology, forensic analysis, and urine drug testing applications.
|100 μg/mL (0.1% HCl in acetonitrile (v/v))|
|2°C (35.6°F) - closed cup|
Safety and Handling
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok
CERILLIANT is a registered trademark of Cerilliant Corporation